Table 2.
Genotype distributions for the four SNPs between GC and control subjects
| Gastric cancer |
Controls |
|||||
|---|---|---|---|---|---|---|
| SNP | Genotype | n (%) | n (%) | OR (95% CI) | P-Value | |
| rs11614913C/T | CC | 39 (24.5) | 101 (19.8) | Ref | ||
| Gastric Cancer, n=159 | CT | 95 (59.7) | 324 (63.4) | 0.759 (0.492-1.173) | 0.214 | |
| Controls, n=511 | TT | 25 (15.7) | 86 (16.8) | 0.753 (0.422-1.343) | 0.336 | |
| CT/TT | 120 (75.5) | 410 (80.2) | Ref | |||
| CC | 39 (24.5) | 101 (19.8) | 1.319 (0.865-2.012) | 0.197 | ||
| rs3746444C/T | CC | 5 (2.6) | 17 (3.4) | Ref | ||
| Gastric Cancer, n=196 | CT | 50 (25.5) | 121 (24.0) | 1.405 (0.492-4.016) | 0.524 | |
| Controls, n=504 | TT | 141 (71.9) | 366 (72.6) | 1.310 (0.474-3.617) | 0.602 | |
| CT/TT | 191 (97.4) | 487 (96.6) | Ref | |||
| CC | 5 (2.6) | 17 (3.4) | 0.750 (0.273-2.061) | 0.576 | ||
| rs2910164G/C | GG | 36 (18.3) | 96 (18.7) | Ref | ||
| Gastric Cancer, n=197 | GC | 96 (48.7) | 274 (53.4) | 0.934 (0.597-1.462) | 0.766 | |
| Controls, n=513 | CC | 65 (33.0) | 143 (27.9) | 1.212 (0.748-1.946) | 0.434 | |
| GG/GC | 132 (67.0) | 370 (72.1) | Ref | |||
| CC | 65 (33.0) | 143 (27.9) | 1.274 (0.894-1.816) | 0.180 | ||
| rs2292832C/T | CC | 22 (11.8) | 48 (10.5) | Ref | ||
| Gastric Cancer, n=187 | CT | 31 (16.6) | 103 (22.4) | 0.657 (0.345-1.251) | 0.200 | |
| Controls, n=459 | TT | 134 (71.7) | 308 (67.1) | 0.949 (0.551-1.635) | 0.851 | |
| CC/CT | 53 (28.3) | 151 (32.9) | Ref | |||
| TT | 134 (71.7) | 308 (67.1) | 1.240 (0.854-1.800) | 0.259 |
SNP: single-nucleotide polymorphism; OR: odds ratio